TITLE

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

AUTHOR(S)
Basch, Ethan; Hesketh, Paul J.; Kris, Mark G.; Prestrud, Ann Alexis; Temin, Sarah; Lyman, Gary H.
PUB. DATE
November 2011
SOURCE
Journal of Oncology Practice;Nov2011, Vol. 7 Issue 6, p395
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the guidelines published by American Society of Clinical Oncology (ASCO) on nausea and vomiting induced by chemotherapy, which includes an evaluation of evidence on complementary antiemetic therapy. The Antiemetics Guideline Update Committee included literature identified by a systematic review funded by the Agency for Healthcare Research and Quality, presentations and posters from the Multinational Association for Supportive Care in Cancer and ASCO Annual Meetings. It reviews optimal therapy for patients receiving highly emetic chemotherapy and recently approved drugs by FDA, including, fosaprepitant, the granisetron transdermal system, and the ondansetron orally disintegrating tablet.
ACCESSION #
78318374

 

Related Articles

  • Clinical Practice Guidelines for Cancer Care: Utilization and Expectations of the Practicing Oncologist. Dillmon, Melissa; Goldberg, John M.; Ramalingam, Suresh S.; Mayer, Robert J.; Loehrer, Patrick; Van Poznak, Catherine // Journal of Oncology Practice;Nov2012, Vol. 8 Issue 6, p350 

    Abstract: ASCO produces guidelines for oncologists, utilizing a systematic review process. Although this resource-intense process results in authoritative and widely cited guidelines, they can cover only a few specific clinical issues. Hence, the ASCO guidelines presently do not fully address...

  • Clinical pathways can lead to better cancer care. GOOZNER, MERRILL // Modern Healthcare;11/24/2014, Vol. 44 Issue 47, p24 

    The article discusses the role of clinical pathways in improving cancer care in the U.S. Topics highlighted include the factors that contributed to improper allocation of health care resources to cancer patients and physicians, provisions of WellPoint's oncology clinical pathways reimbursement...

  • Commentary: Should Cost and Comparative Value of Treatments Be Considered in Clinical Practice Guidelines? Basch, Ethan; Somerfield, Mark R.; Partridge, Ann; Schnipper, Lowell; Lyman, Gary H. // Journal of Oncology Practice;Nov2011, Vol. 7 Issue 6, p398 

    The author comments on the article "Bending the cost curve in cancer care," by TJ Smith and colleagues. He connotes that the article reflects on the increasing cost of cancer treatment comprising cancer diagnostics and therapeutics in the United States. Centers for Medicare and Medicaid Services...

  • Communicating Safe Outpatient Management of Fever and Neutropenia. Flowers, Christopher R.; Karten, Clare // Journal of Oncology Practice;Jul2013, Vol. 9 Issue 4, p207 

    The authors discuss the significance of communicating the guideline "Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy," by American Clinical Society of Oncology (ASCO) Clinical Practice Guidelines Committee, to practicing clinicians....

  • Ensuring That Guidelines Help Reduce Patient Harm. Pronovost, Peter J. // Journal of Oncology Practice;Jul2013, Vol. 9 Issue 4, pe172 

    The author discusses ways to ensure that the American Society of Clinical Oncology (ASCO) guidelines reduce preventable patient harm. He states that the recommendations for care and placement of central venous catheters (CVC) for pediatric and adult patients with cancer aims to lessen patient...

  • Do Wise Choices Translate Into Cost Savings and Improved Outcomes? Blayney, Douglas W. // Journal of Oncology Practice;Jul2015, Vol. 11 Issue 4, p344 

    The article presents the author's comments on the article "Baseline estimates of adherence to ASCO/ABIM Choosing Wisely (CW) Initiative among patients with cancer enrolled in a large regional commercial health insurer," by S.D. Ramsey and colleagues in the current issue. According to the author,...

  • ASCO's Approach to a Learning Health Care System in Oncology. Sledge, George W.; Hudis, Clifford A.; Swain, Sandra M.; Yu, Peter M.; Mann, Joshua T.; Hauser, Robert S.; Lichter, Allen S. // Journal of Oncology Practice;May2013, Vol. 9 Issue 3, p145 

    The article discusses what a learning health care system looks like and the key features of a learning health care system in oncology. The efforts undertaken by the American Society of Clinical Oncology (ASCO) volunteers, led by an Advisory Committee and supported by expert staff and outside...

  • HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology. Bartley, Angela N.; Washington, Mary Kay; Ismaila, Nofisat; Ajani, Jaffer A. // Journal of Oncology Practice;Jan2017, Vol. 13 Issue 1, p53 

    The article presents the guideline summary on anti-human epithelial growth factor 2 (HER2) testing and clinical decision making for gastroesophageal adenocarcinoma (GEA) from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology....

  • Cancer Care: Practice Guidelines Assign Grade "A" Recommendation for Meditation. Hart, Jane // Alternative & Complementary Therapies;Feb2020, Vol. 26 Issue 1, p28 

    The article focuses on the advancements in the field of integrative oncology highlight the growing body of evidence that supports the use of mind– body therapies in cancer care; and mentions the progress that is occurring in terms of raised awareness regarding the strength of evidence for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics